Is a procalcitonin level of 0.12 clinically significant in a patient with suspected bacterial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Procalcitonin 0.12 ng/mL: Clinical Significance

A procalcitonin level of 0.12 ng/mL is NOT clinically significant for bacterial infection and indicates a very low probability of bacterial sepsis or serious bacterial infection. 1

Interpretation Based on Established Thresholds

Your value of 0.12 ng/mL falls well below all clinically meaningful cut-offs for bacterial infection:

  • Values <0.25 ng/mL indicate low probability of bacterial infection and can support withholding or early discontinuation of antibiotics when combined with clinical assessment 1
  • The American Thoracic Society guidelines specifically identify 0.1-0.25 ng/mL as suggesting low probability of bacterial infection, though not completely ruling it out 1
  • The optimal diagnostic cut-off for bacterial infection in critically ill patients is 0.5 ng/mL, with your value being less than one-quarter of this threshold 2

Clinical Context and Decision-Making

Do not use this procalcitonin value alone to make antibiotic decisions. The American Thoracic Society and Infectious Diseases Society of America explicitly state that procalcitonin cannot be used as the sole determinant for initiating or withholding antibiotics 1

For patients with suspected bacterial infection and PCT 0.12 ng/mL:

  • If clinical suspicion for bacterial infection is low-to-intermediate, this PCT value supports withholding antibiotics or discontinuing them within 24 hours if already started 1
  • If clinical suspicion is high (fever ≥38°C, pleuritic pain, dyspnea, new chest findings), initiate antibiotics regardless of this low PCT value 1
  • Consider C-reactive protein >30 mg/L, which has superior diagnostic performance compared to procalcitonin (area under ROC curve 0.79 vs 0.68) 3

Negative Predictive Value

This low PCT level has excellent negative predictive value for serious bacterial infection:

  • Normal PCT levels (<0.5 ng/mL) have 96-98.6% negative predictive value for bacterial infections, particularly gram-negative infections 4
  • PCT <0.25 ng/mL has been shown to reduce antibiotic use by more than half without increasing mortality when used for antibiotic stewardship 1

Important Caveats

Be aware of specific clinical scenarios where PCT interpretation differs:

  • Congestive heart failure: In patients with heart failure, the cut-off values are lower (0.086 μg/L for Class II, 0.192 μg/L for Class III heart failure), meaning your value of 0.12 could be more significant in this population 5
  • Timing matters: PCT rises within 2-3 hours of infection onset, so if symptoms just began, consider repeat measurement in 6-12 hours 1
  • Certain pathogens (Legionella, Mycoplasma) may not elevate PCT even with active infection 1
  • 21% of COVID-19 patients without bacterial pneumonia can have elevated PCT, but your value is well below concerning thresholds 1

Practical Algorithm

  1. PCT 0.12 ng/mL + low clinical suspicion → Withhold antibiotics, observe clinically 1
  2. PCT 0.12 ng/mL + moderate clinical suspicion → Consider CRP; if CRP <30 mg/L, withhold antibiotics 3
  3. PCT 0.12 ng/mL + high clinical suspicion → Initiate antibiotics based on clinical assessment, not PCT 1
  4. PCT 0.12 ng/mL + congestive heart failure Class III-IV → Interpret with caution; this value may be more significant 5

References

Guideline

Procalcitonin Elevation Causes and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approaches for Bacterial Infections in Cavitary Lung Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Procalcitonin Guidance in Lymphoma Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.